BioCardia, Inc. (NASDAQ:BCDA) Q4 2025 Earnings Call Transcript

BioCardia, Inc. (NASDAQ:BCDA) Q4 2025 Earnings Call Transcript March 24, 2026

BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.17.

Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia Year-end 2025 Financial Results and Business Update Conference Call. [Operator Instructions] Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is...